Aller au contenu principal
Profil bibliographique

Christos Papadimitriou

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

37Publications signalées
47Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Breast Cancer Treatment StudiesOvarian cancer diagnosis and treatmentCancer Risks and FactorsCancer Treatment and PharmacologyCancer, Lipids, and Metabolism

Les publications récentes

Accès ouvert 2026 article OpenAlex

Fallopian Tube Cytology for Exploratory Detection of Adnexal Malignancy: Prospective Evaluation of the CytoSaLPs Score in an Ex Vivo Surgical Cohort

Victoria Psomiadou, Sofia Lekka, Theodoros Panoskaltsis, Abraham Pouliakis et autres

Objective: Ovarian, fallopian tube, and primary peritoneal cancers are the deadliest gynecological malignancies, largely due to delayed diagnosis, tumor heterogeneity, and lack of effective methods for early detection. Increasing evidence suggests that most high-grade serous ovarian carcinomas originate from the fallopian tube …

0 citations Cancers
Accès ouvert 2026 article OpenAlex

Safety and efficacy of delivering systemic treatments concomitantly with whole-brain radiotherapy: a prospective, observational, single-institution study

Maria Protopapa, Kalliopi Platoni, Michalis Psarras, Styliani-Theonymfi Nikoloudi et autres

Aim: The aim of our study was to evaluate the safety and efficacy of delivering systemic treatments concurrently with whole-brain radiotherapy (WBRT). Methods: A single-institution, prospective observational study was conducted in Athens, Greece, including 99 patients treated with WBRT for brain metastases …

gr (code pays fourni par la source)

0 citations Exploration of Targeted Anti-tumor Therapy
Accès ouvert 2026 conference-abstract OpenAlex

EP1733 - LBA_ECE_1473 - The role of pembrolizumab immunotherapy in metastatic adrenocortical carcinoma: a case series study

Kyriaki Gkoufa, Ariadni Spyroglou, Maria Theochari, Odysseas Violetis et autres

Abstract Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with a poor prognosis in advanced stages. Standard first-line treatment for metastatic disease involves mitotane and cytotoxic chemotherapy (EDP-M); however, therapeutic options following progression are limited. Immunotherapy with immune checkpoint inhibitors, such …

gr (code pays fourni par la source)

0 citations European Journal of Endocrinology
Accès ouvert 2026 article OpenAlex

Lipid Profiles in Breast Cancer: Clinical Associations and Biological Insights

Anastasia Nikolakopoulou, Kalliopi Stavrati, Constantinos Nastos, Dimitrios Papaconstantinou et autres

Alterations in lipid metabolism are increasingly recognized as important contributors to breast cancer biology. Lipids regulate membrane structure, intracellular signaling, and energy homeostasis, and cancer cells undergo lipid metabolic reprogramming to support tumor growth and progression. This narrative review summarizes current evidence …

gr (code pays fourni par la source)

0 citations Cancer Diagnosis & Prognosis
Accès ouvert 2026 article OpenAlex

Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women With Breast Cancer Receiving Hormonal Therapy

Anastasia Nikolakopoulou, Constantinos Nastos, Dimitrios Papakonstantinou, Kalliopi E. Stavrati et autres

BACKGROUND AND AIM: Hormonal modulation therapy is an important component of hormone receptor-positive breast cancer treatment. However, the type and duration of hormonal therapies have distinct effects on lipid profile parameters and cardiovascular disease risk. This study aimed to investigate the impact …

gr (code pays fourni par la source)

0 citations Cureus
Accès ouvert 2026 article OpenAlex

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon, Jung-Yun Lee et autres

Plain Language SummaryWhat is this summary about?There are only a few current treatment options for people with newly diagnosed advanced or recurrent endometrial cancer (cancer that has returned). The DUO-E study is testing an immunotherapy, durvalumab, and a targeted therapy, olaparib, in …

us, kr, il, jp, cn, co, br, de, pl, gr, es, lt, sg, nl (code pays fourni par la source)

0 citations Future Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.